Dopamine antagonist speeds up tail regeneration in lizards exposed to continuous darkness: evidence for prolactin involvement.
In earlier studies, we demonstrated that continuous light (LL:LD, 24:0) stimulated tail regeneration whereas continuous darkness (DD:LD, 0:24) and pinealectomy depressed the same in the Gekkonid lizard, Hemidactylus flaviviridis, and, furthermore, exogenous prolactin significantly enhanced the regeneration process in lizards kept in 0:24 LD. However, the regeneration process in animals exposed to 24:0 LD was unaffected by the dopamine agonist, bromocriptine. This study with pimozide, an antipsychotic drug, and a potent dopamine receptor antagonist was conducted to ascertain whether the dopaminergic regulation of prolactin release is operative in lizards, as in mammals, and to provide further evidence for prolactin involvement in regenerative growth. Once daily intraperitoneal injection of 50 micrograms/kg pimozide to H. flaviviridis, 5 days prior to tail autotomy and 50 days thereafter, stimulated the regeneration process in lizards exposed to 0:24 LD. The initiation of regeneration, the total length of new growth (regenerate) produced by Day 50, and the total percentage replacement of the lost (autotomized) tails at the end of 50 days of experimentation were all significantly enhanced in pimozide-treated animals as compared with their counterparts injected with 0.6% sterile saline; in fact, better than saline-injected controls exposed to 24:0 LD of 638 lux intensity. The daily growth rate was also enhanced in pimozide-treated lizards. Interestingly, the pattern of regeneration as well as the final regenerate of pimozide-treated lizards were similar to those observed earlier in ovine prolactin-treated animals exposed to similar experimental photoperiodic schedules.(ABSTRACT TRUNCATED AT 250 WORDS)
Ndukuba
P I
PI
Department of Zoology, M. S. University of Baroda, Gujarat State, India.
Ramachandran
A V
AV
D000818:Animals; D018492:Dopamine Antagonists; D008116:Lizards / Q000502:physiology*; D010868:Pimozide / Q000494:pharmacology*; D011388:Prolactin / Q000502:physiology*; D012016:Reference Values; D012038:Regeneration / Q000187:drug effects*; D013623:Tail
D018492:Dopamine Antagonists; D010868:Pimozide; D011388:Prolactin